Literature DB >> 17973119

APC promoter methylation and protein expression in hepatocellular carcinoma.

Antal Csepregi1, Christoph Röcken, Juliane Hoffmann, Ping Gu, Stephan Saliger, Oliver Müller, Regine Schneider-Stock, Nadine Kutzner, Albert Roessner, Peter Malfertheiner, Matthias P A Ebert.   

Abstract

PURPOSE: We investigated the impact of promoter methylation on APC protein expression in patients with hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: 50 patients [HCC (n=19), liver metastasis (n=19), cholangiocellular cancer (n=7), and benign liver tumors (n=5)] were studied for methylation using Methylight analysis. APC mutation was investigated by protein truncation test and direct sequencing of genomic DNA. The protein expression was evaluated by immunohistochemistry and Western blot analysis.
RESULTS: The APC promoter was hypermethylated in 81.8% of non-cancerous liver tissue samples. All HCC samples and ten patients with liver metastasis (52.6%) exhibited APC promoter methylation. The degree of methylation was significantly higher in samples from HCC compared to the non-cancerous liver tissue samples (63.1% vs. 24.98%; p=0.001). The level of APC protein expression was significantly reduced in HCC samples compared to that of the corresponding non-tumor liver tissue (p<0.05).
CONCLUSIONS: Promoter methylation of the APC gene seems to be of significance in hepatocarcinogenesis and results in reduced protein expression in HCC. Interestingly, APC promoter methylation is also present in the vast majority of non-cancerous liver tissue whose (patho)physiological function remains unresolved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17973119      PMCID: PMC2757596          DOI: 10.1007/s00432-007-0321-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  20 in total

Review 1.  The essentials of DNA methylation.

Authors:  A Bird
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

2.  Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta.

Authors:  J Behrens; B A Jerchow; M Würtele; J Grimm; C Asbrand; R Wirtz; M Kühl; D Wedlich; W Birchmeier
Journal:  Science       Date:  1998-04-24       Impact factor: 47.728

Review 3.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

4.  Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia.

Authors:  T Tsuchiya; G Tamura; K Sato; Y Endoh; K Sakata; Z Jin; T Motoyama; O Usuba; W Kimura; S Nishizuka; K T Wilson; S P James; J Yin; A S Fleisher; T Zou; S G Silverberg; D Kong; S J Meltzer
Journal:  Oncogene       Date:  2000-07-27       Impact factor: 9.867

5.  Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma.

Authors:  M O Hiltunen; L Alhonen; J Koistinaho; S Myöhänen; M Pääkkönen; S Marin; V M Kosma; J Jänne
Journal:  Int J Cancer       Date:  1997-03-17       Impact factor: 7.396

6.  Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.

Authors:  S J Laken; G M Petersen; S B Gruber; C Oddoux; H Ostrer; F M Giardiello; S R Hamilton; H Hampel; A Markowitz; D Klimstra; S Jhanwar; S Winawer; K Offit; M C Luce; K W Kinzler; B Vogelstein
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

7.  Distinct methylation patterns of benign and malignant liver tumors revealed by quantitative methylation profiling.

Authors:  Ulrich Lehmann; Ina Berg-Ribbe; Luzie U Wingen; Kai Brakensiek; Thomas Becker; Jürgen Klempnauer; Brigitte Schlegelberger; Hans Kreipe; Peer Flemming
Journal:  Clin Cancer Res       Date:  2005-05-15       Impact factor: 12.531

Review 8.  Epidemiology of primary liver cancer.

Authors:  F X Bosch; J Ribes; J Borràs
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

Review 9.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Andrew Burroughs; Jordi Bruix
Journal:  Lancet       Date:  2003-12-06       Impact factor: 79.321

10.  Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis.

Authors:  Jie Chen; Christoph Röcken; Cathy Lofton-Day; Hans-Ulrich Schulz; Oliver Müller; Nadine Kutzner; Peter Malfertheiner; Matthias P A Ebert
Journal:  Carcinogenesis       Date:  2004-09-16       Impact factor: 4.944

View more
  23 in total

Review 1.  Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.

Authors:  Renumathy Dhanasekaran; Jean-Charles Nault; Lewis R Roberts; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2018-11-04       Impact factor: 22.682

Review 2.  Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes.

Authors:  Yuan-Chi Teng; Zhao-Qing Shen; Cheng-Heng Kao; Ting-Fen Tsai
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

3.  Prognostic value of Wnt inhibitory factor-1 expression in hepatocellular carcinoma that is independent of gene methylation.

Authors:  Liang Huang; Mei-Xiang Li; Li Wang; Bin-Kui Li; Gui-Hua Chen; Li-Ru He; Li Xu; Yun-Fei Yuan
Journal:  Tumour Biol       Date:  2010-10-30

4.  Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma.

Authors:  Eric J Formeister; Masato Tsuchiya; Hideki Fujii; Svitlana Shpyleva; Igor P Pogribny; Ivan Rusyn
Journal:  Mutat Res       Date:  2010-08-22       Impact factor: 2.433

Review 5.  Clinical implications of DNA methylation in hepatocellular carcinoma.

Authors:  Eric L Sceusi; David S Loose; Curtis J Wray
Journal:  HPB (Oxford)       Date:  2011-03-29       Impact factor: 3.647

6.  DNA methyltransferase 3b silencing affects locus-specific DNA methylation and inhibits proliferation, migration and invasion in human hepatocellular carcinoma SMMC-7721 and BEL-7402 cells.

Authors:  Jia-Chen Wang; Zhao Wang; Yu-Xia Fan; Ya-Qing Si; Jia-Xiang Wang
Journal:  Oncol Lett       Date:  2015-03-26       Impact factor: 2.967

7.  Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies.

Authors:  James P Hamilton
Journal:  Epigenomics       Date:  2010-04-01       Impact factor: 4.778

Review 8.  DNA markers in molecular diagnostics for hepatocellular carcinoma.

Authors:  Ying-Hsiu Su; Selena Y Lin; Wei Song; Surbhi Jain
Journal:  Expert Rev Mol Diagn       Date:  2014-08-07       Impact factor: 5.225

9.  Folate rescues lithium-, homocysteine- and Wnt3A-induced vertebrate cardiac anomalies.

Authors:  Mingda Han; Maria C Serrano; Rosana Lastra-Vicente; Pilar Brinez; Ganesh Acharya; James C Huhta; Ren Chen; Kersti K Linask
Journal:  Dis Model Mech       Date:  2009-07-28       Impact factor: 5.758

10.  Building Classification Models with Combined Biomarker Tests: Application to Early Detection of Liver Cancer.

Authors:  Dion Chen; Surbhi Jain; Ying-Hsu Su; Wei Song
Journal:  J Stat Sci Appl       Date:  2017 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.